Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1992-05-11
1993-02-02
Friedman, S. J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A61K 31495
Patent
active
051838192
ABSTRACT:
The invention relates to a method of treating alcoholism, sleep disorders or behavioral symptoms of Alzheimer's disease which comprises administration of bridged 2-(4-arylpiperazin-1-ylalkyl)-hexahydroisoindol-1,3-dione derivatives to a warm-blooded animal in need thereof.
REFERENCES:
patent: 4797488 (1989-01-01), Stack
patent: 4892943 (1990-01-01), Abou-Gharbia
patent: 4895848 (1990-01-01), Traber
patent: 5010078 (1991-04-01), Abou-Gharbia
Abou-Gharbia et al., J. Med. Chem. 31, 1382-92 (1988).
White et al., Pharmacology Biochemistry and Behavior 39, 729-736 (1988).
Olivier et al., Drugs of the Future 11(6), 473.sub.]94 (1986).
Collins and Myers, Alcohol 4, 49-56 (1987).
Wauguier and Dugovie, Ann. N.Y. Acad. Sci. 600, 447-459 (1990).
Abou-Gharbia Magid A. M.
Moyer John A.
American Home Products Corporation
Boswell, Jr. Robert F.
Friedman S. J.
LandOfFree
Use of fused bicyclic imides in the treatment of various CNS dis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of fused bicyclic imides in the treatment of various CNS dis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of fused bicyclic imides in the treatment of various CNS dis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-7023